Oncogenic Signaling Pathways Activated by RON Receptor Tyrosine Kinase

被引:58
作者
Danilkovitch-Miagkova, Alla [1 ]
机构
[1] PPD Dev, Dept Immunochem, Richmond, VA 23230 USA
关键词
D O I
10.2174/1568009033333745
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
RON (Receptuer d'Origine Nantaise) is a member of the MET receptor tyrosine kinase family. RON is expressed in various cell types including macrophages, epithelial and hematopoietic cells. Its ligand, macrophage stimulating protein (MSP, also known as hepatocyte growth factor-like protein), is a multifunctional factor regulating cell growth and survival, adhesion and motility, cytokine production and phagocytosis. Accumulated data indicate that in addition to the regulation of normal cell functions, RON can be involved in cancer development and progression: (i) RON is overexpressed and constitutively active in some primary tumors and tumor cell lines; (ii) experimental mutations of RON cause oncogenic cell transformation, and (iii) RON mediates susceptibility to Friend-virus-induced erythroleukemia in mice. Constitutive activation of intracellular signaling pathways such as the PI-3 kinase/AKT, beta-catenin, MAPK and JNK pathways may underlie the molecular mechanism of RON-mediated oncogenic cell transformation. The present review describes RON-activated signaling pathways, which may play an important role in tumor formation and metastasis.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 75 条
[1]   Concomitant activation of the PI3K-Akt and the Ras-ERK signaling pathways is essential for transformation by the V-SEA tyrosine kinase oncogene [J].
Agazie, Y ;
Ischenko, I ;
Hayman, M .
ONCOGENE, 2002, 21 (05) :697-707
[2]  
Angeloni D, 2000, GENE CHROMOSOME CANC, V29, P147, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1015>3.0.CO
[3]  
2-N
[4]  
Banu N, 1996, J IMMUNOL, V156, P2933
[5]   Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth [J].
Bardelli, A ;
Longati, P ;
Gramaglia, D ;
Basilico, C ;
Tamagnone, L ;
Giordano, S ;
Ballinari, D ;
Michieli, P ;
Comoglio, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) :14379-14383
[6]   APC: the plot thickens [J].
Bienz, M .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (05) :595-603
[7]  
BONNE C., 1939, AMER JOUR CANCER, V35, P491
[8]  
Bullions Linda C., 1998, Current Opinion in Oncology, V10, P81, DOI 10.1097/00001622-199801000-00013
[9]  
Chen QY, 1997, HEPATOLOGY, V26, P59
[10]  
Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO